相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
N. Colombo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer
Isabelle Ray-Coquard et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Pembrolizumab for the treatment of cervical cancer
Gregoire Marret et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
Phase 1b trial of nintedanib in combination with bevacizumab in patients with advanced solid tumors
Ravi Paluri et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2019)
The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the Management of Patients With Cervical Cancer
David Cibula et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505
Ryo Kitagawa et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial
Martin Reck et al.
LANCET ONCOLOGY (2014)
Improved Survival with Bevacizumab in Advanced Cervical Cancer
Krishnansu S. Tewari et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Resistance and Escape From Antiangiogenesis Therapy: Clinical Implications and Future Strategies
Justin N. Bottsford-Miller et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
European Network of Gynaecological Oncological Trial Groups' Requirements for Trials Between Academic Groups and Pharmaceutical Companies
Ignace Vergote et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
BIBF 1120: Triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy
Frank Hilberg et al.
CANCER RESEARCH (2008)
The European Organization for Research and Treatment of Cancer (EORTC) quality-of-life questionnaire cervical cancer module - EORTC QLQ-CX24
Elfriede R. Greimel et al.
CANCER (2006)
分享论文
